FDA Import Refusal SCS-2240866-7/10002/1 — OXYMORON AG
The FDA refused shipment SCS-2240866-7/10002/1 from OXYMORON AG (Switzerland) on April 6, 2026. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- April 6, 2026
- Country
- Switzerland
- Product Category
- Drugs and Biologics
- Product Code
- 66VCY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,3280,75